Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib

Published:2016-07-21 Issue:5 Volume:9 Page:260-266
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Karovic S¹,Shiuan EF²,Zhang SQ¹,Cao H³,Maitland ML¹⁴⁵

Affiliation:

1. Section of Hematology/Oncology Department of Medicine University of Chicago Chicago Illinois USA

2. Department of Biochemistry & Molecular Biology University of Chicago Chicago Illinois USA

3. Department of Health Studies University of Chicago Chicago Illinois USA

4. Committee on Clinical Pharmacology and Pharmacogenomics University of Chicago Chicago Illinois USA

5. Comprehensive Cancer Center University of Chicago Chicago Illinois USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12408

Reference31 articles.

1. Targeting cancer with small molecule kinase inhibitors

2. Comprehensive analysis of kinase inhibitor selectivity

3. Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

4. A quantitative analysis of kinase inhibitor selectivity

5. Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents;Cell Communication and Signaling;2024-04-15

2. Dose Individualization of Oral Multi-Kinase Inhibitors for the Implementation of Therapeutic Drug Monitoring;Biological and Pharmaceutical Bulletin;2022-07-01

3. Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation;Hepatology Communications;2021-08-27

4. Osteonecrosis of the External Auditory Canal Associated With Oral Sorafenib Therapy: Sorafenib and Temporal Bone Osteonecrosis;Otology & Neurotology;2019-09

5. Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies;Clinical Cancer Research;2019-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3